- Home
- BCYC vs ZIMV Comparison
BCYC vs ZIMV Comparison
Compare BCYC & ZIMV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- ZIMV
- Stock Information
- Founded
- BCYC 2009
- ZIMV 2021
- Country
- BCYC United Kingdom
- ZIMV United States
- Employees
- BCYC N/A
- ZIMV N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BCYC Health Care
- ZIMV Health Care
- Exchange
- BCYC Nasdaq
- ZIMV Nasdaq
- Market Cap
- BCYC 492.1M
- ZIMV 532.3M
- IPO Year
- BCYC 2019
- ZIMV N/A
- Fundamental
- Price
- BCYC $7.96
- ZIMV $18.93
- Analyst Decision
- BCYC Buy
- ZIMV Hold
- Analyst Count
- BCYC 11
- ZIMV 3
- Target Price
- BCYC $22.91
- ZIMV $14.50
- AVG Volume (30 Days)
- BCYC 303.4K
- ZIMV 323.0K
- Earning Date
- BCYC 10-30-2025
- ZIMV 10-29-2025
- Dividend Yield
- BCYC N/A
- ZIMV N/A
- EPS Growth
- BCYC N/A
- ZIMV N/A
- EPS
- BCYC N/A
- ZIMV N/A
- Revenue
- BCYC $19,281,000.00
- ZIMV $443,402,000.00
- Revenue This Year
- BCYC N/A
- ZIMV $2.49
- Revenue Next Year
- BCYC N/A
- ZIMV $1.26
- P/E Ratio
- BCYC N/A
- ZIMV N/A
- Revenue Growth
- BCYC N/A
- ZIMV N/A
- 52 Week Low
- BCYC $6.10
- ZIMV $8.15
- 52 Week High
- BCYC $28.67
- ZIMV $19.01
- Technical
- Relative Strength Index (RSI)
- BCYC 58.20
- ZIMV 72.82
- Support Level
- BCYC $7.40
- ZIMV $18.87
- Resistance Level
- BCYC $8.69
- ZIMV $18.99
- Average True Range (ATR)
- BCYC 0.38
- ZIMV 0.03
- MACD
- BCYC 0.11
- ZIMV -0.08
- Stochastic Oscillator
- BCYC 62.23
- ZIMV 48.00
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.